These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer. Garon EB Semin Oncol; 2015 Oct; 42 Suppl 2():S11-8. PubMed ID: 26477470 [TBL] [Abstract][Full Text] [Related]
31. Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic. Kang SP; Gergich K; Lubiniecki GM; de Alwis DP; Chen C; Tice MAB; Rubin EH Ann Oncol; 2017 Jun; 28(6):1388-1398. PubMed ID: 30052728 [No Abstract] [Full Text] [Related]
32. The small-cell lung cancer drug market. Dawkins JBN; Webster RM Nat Rev Drug Discov; 2020 Aug; 19(8):507-508. PubMed ID: 32235872 [No Abstract] [Full Text] [Related]
33. Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy. La-Beck NM; Jean GW; Huynh C; Alzghari SK; Lowe DB Pharmacotherapy; 2015 Oct; 35(10):963-76. PubMed ID: 26497482 [TBL] [Abstract][Full Text] [Related]
35. Diabetic Ketoacidosis as an Immune-related Adverse Event from Pembrolizumab in Non-Small Cell Lung Cancer. Leonardi GC; Oxnard GR; Haas A; Lang JP; Williams JS; Awad MM J Immunother; 2017; 40(6):249-251. PubMed ID: 28557813 [TBL] [Abstract][Full Text] [Related]
36. Durable Response After 2 Doses of Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer With an Isolated Brain Metastasis. Uprety D; Arjyal L; Vallatharasu Y; Bista A; Wittchow RJ; Marinier DE Clin Lung Cancer; 2019 Sep; 20(5):e552-e554. PubMed ID: 31285178 [No Abstract] [Full Text] [Related]
37. A rapid response to pembrolizumab in a patient with metastatic melanoma. Bayo Calero J; Aviñó Tarazona V Immunotherapy; 2017 Mar; 9(3):225-228. PubMed ID: 28231724 [TBL] [Abstract][Full Text] [Related]
38. Immune Checkpoint Inhibitor-Associated Central Adrenal Insufficiency. Mishra T; He G; Sreeram K; Rauf M; Subahi A; Hazem M Am J Ther; 2019; 26(5):e626-e627. PubMed ID: 30277909 [No Abstract] [Full Text] [Related]
39. Thoracic Imaging of Non-Small Cell Lung Cancer Treated With Anti-programmed Death Receptor-1 Therapy. Hammer M; Bagley S; Aggarwal C; Bauml J; Nachiappan AC; Simone CB; Langer C; Katz SI Curr Probl Diagn Radiol; 2019; 48(2):142-147. PubMed ID: 29573843 [TBL] [Abstract][Full Text] [Related]
40. American Association of Cancer Research Showcases Immunotherapy Advances. Brower V J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26243202 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]